Brimonidine Tartrate Solution/ Drops
Product Images NDC 60505-0577

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 60505-0577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-10ml.jpg (Btl Lbl 10ml)

Label of Brimonidine Tartrate Ophthalmic Solution 0.1% (equivalent to 1 mg/mL) in a 10 mL bottle. The label shows the NDC 60505-0577, indicates sterility, and states the product is Rx only. Manufacturer listed is Apotex Corp., Toronto, Canada. Storage and dosage guidance appear on the label.*

FDA Label Image

Btl-lbl-15ml.jpg (Btl Lbl 15ml)

Brimonidine Tartrate Ophthalmic Solution 0.1% label for a 15 mL bottle. The label includes the product name and strength, indicates it is sterile and prescription only, and shows it is manufactured by Apotex Corp. Storage instructions at 20°C to 25°C are provided along with dosage information for ophthalmic use.*

FDA Label Image

Btl-lbl-5ml.jpg (Btl Lbl 5ml)

Label for Brimonidine Tartrate Ophthalmic Solution 0.1% (1 mg/mL) in a 5 mL bottle. The label includes the NDC 60505-0577-1, indicates sterile solution, Rx only, and is manufactured by Apotex Corp., Toronto, Ontario, Canada. Dosage instructions and storage temperature are also visible.*

FDA Label Image

Ctn-lbl-10ml.jpg (Ctn Lbl 10ml)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1% (1 mg/mL) by Apotex Corp. It is a sterile eye drop solution supplied in a 10 mL container. The label includes active ingredient, preservative, inactive ingredients, storage instructions, dosage, tamper evidence, and manufacturer information. The label displays the NDC 60505-0577-2 and features branding with Apotex Corp. logos.*

FDA Label Image

Ctn-lbl-15ml.jpg (Ctn Lbl 15ml)

Brimonidine Tartrate Ophthalmic Solution 0.1% label by Apotex Corp. The label indicates a 15 mL solution with active ingredient brimonidine tartrate 0.1%, intended for prescription use only and is sterile. It includes ingredient details, storage instructions (20°C to 25°C), dosage direction (one drop three times daily), tamper evident notice, and manufacturing information for Apotex Inc. and Apotex Corp. Barcode and standard drug packaging elements are visible.*

FDA Label Image

Ctn-lbl-5ml.jpg (Ctn Lbl 5ml)

Box packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, 5 mL, manufactured by Apotex Corp. The label features the product name in white text on a purple background with green and blue stripes underneath. The label includes active and inactive ingredients, storage instructions, dosage directions, and manufacturer information. The product is sterile and Rx only.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of brimonidine tartrate displayed with labeled atoms and bonds, showing the arrangement of its molecular components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.